Tert-butyln-{[3-(hydroxymethyl)oxetan-3-yl]methyl}carbamate, 98%, 500mg

(R)-1-N-Boc-3-Hydroxy-pyrrolidine, 97.0%, 100g

(3aS,4R,7aS)-2-(tert-Butoxycarbonyl)octahydro-1H-isoindole-4-carboxylic acid, 98+%, 250mg

Trietilenglicol, mínimo 98%, para síntesis, 2,5 L, envase de vidrio

3-Bromo-1-propanol>93.0%(GC)250g

(2-furylmethyl)(2-pyridinylmethyl)amine oxalate, 95.0%, 5g

Benzyltrimethylammonium tribromide, 95.0%, 5g

(S)-2-(3-((1R,2R)-2-Aminocyclohexyl)thioureido)-N-benzyl-N,3,3-trimethylbutanamide, 98%, 50mg

Trifluoroacetaldehyde ethyl hemiacetal, 85.0%, 5g

p-Hexyloxybenzalazine, 1g

N-Methoxy-N,6-dimethylnicotinamide, 95+%, 1g

7-Methylene-2-oxaspiro[3.5]nonane, 1g

Methyl 6-methylpyrazine-2-carboxylate, 95.0%, 25g